Literature DB >> 32057857

Degradation of different molecular weight fucoidans and their inhibition of TGF-β1 induced epithelial-mesenchymal transition in mouse renal tubular epithelial cells.

Xiaosong Li1, Ning Wu2, Yongqiang Chen3, Jiaojiao Tan1, Jing Wang2, Lihua Geng2, Yimin Qin4, Quanbin Zhang5.   

Abstract

In order to investigate the anti-fibrotic effect of different molecular weight (Mw) fucoidans on TGF-β1-induced mouse renal tubular epithelial cell (MTEC) mode. Oxidative degradation method was used to obtain fucoidans with different molecular weights and the reaction time, reaction temperature and the concentration of oxidants were investigated. Cell viability was detected by CCK-8, and EMT markers expression was detected by Western-bolt and Cell immunofluorescence assay. As a result, after chemical analysis of three independent batches of prepared samples, one batch of fucoidan sample (LHX 1-9) which chemical contents are similar but Mw ranging from 3.3 KDa to 49.3 KDa were selected to do further research. We found LHX1 (Mw = 3.3 KDa) and LHX 3-9 (Mw = 6.6 KDa, 8.3 KDa, 11.3 KDa, 14.9 KDa, 25.2 KDa, 35.4 KDa, 49.3 KDa) could resist the TGF-β1-induced depithelial-mesenchymal transition (EMT) by decreased expression of Fn and CTGF and maintained epithelial cell morphology in MTEC. However, the relationship between the Mw of fucoidans and their anti-EMT effect is not simply linear. Among the samples, LHX 1, 5 and 8 showed significant anti-EMT effects than others by de-regulated Fn and CTGF expression on MTEC cells.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Degradation; Epithelial–mesenchymal transition; Fucoidan; Kidney fibrosis

Mesh:

Substances:

Year:  2020        PMID: 32057857     DOI: 10.1016/j.ijbiomac.2020.02.068

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  4 in total

Review 1.  Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases.

Authors:  Minyang Fu; Dandan Peng; Tianxia Lan; Yuquan Wei; Xiawei Wei
Journal:  Acta Pharm Sin B       Date:  2022-01-19       Impact factor: 14.903

Review 2.  The Evolving Role of Natural Compounds in the Medical Treatment of Uterine Fibroids.

Authors:  Michał Ciebiera; Mohamed Ali; Lillian Prince; Tia Jackson-Bey; Ihor Atabiekov; Stanisław Zgliczyński; Ayman Al-Hendy
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

3.  Fucoidan-Mediated Inhibition of Fibrotic Properties in Oral Submucous Fibrosis via the MEG3/miR-181a/Egr1 Axis.

Authors:  Chih-Yuan Fang; Szu-Han Chen; Chun-Chung Huang; Yi-Wen Liao; Shih-Chi Chao; Cheng-Chia Yu
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-05

4.  Low Molecular Weight, 4-O-Sulfation, and Sulfation at Meta-Fucose Positively Promote the Activities of Sea Cucumber Fucoidans on Improving Insulin Resistance in HFD-Fed Mice.

Authors:  Shiwei Hu; Sichun Chen; Hongli Zhu; Mengyu Du; Wei Jiang; Yu Liu; Xiang Gao; Laijin Su; Yangli Xu
Journal:  Mar Drugs       Date:  2021-12-29       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.